
Google Research and Google DeepMind have demonstrated AMIE, a medical AI system, conducting real-time video consultations in a first-of-its-kind study. Built on Gemini and Project Astra, AMIE interprets visual and auditory cues, guides virtual physical exams, and makes diagnostic reasoning in real time.
Clinical evaluators rated it favorably on history-taking, diagnostic accuracy, management appropriateness, and communication quality, and patient actors preferred video over text chat.
However, the company notes AMIE remains a research system and more work is needed before it can be deployed responsibly in real clinical settings.
What happened
Google Research and Google DeepMind have advanced AMIE, a research medical AI system built on Gemini and Project Astra, to conduct real-time clinical video consultations. In a randomized study with simulated consultations, clinical evaluators assessed AMIE favorably across history-taking, diagnostic accuracy, management appropriateness, and communication quality, and patient actors preferred video consultations over text chat.
Why it matters
AMIE can now interpret visual and auditory cues, guide virtual physical exams, and reason diagnostically in real time — capabilities that go beyond text-based AI. This represents a step toward AI systems that can observe physical signs like cough, gait, and visible discomfort, which human doctors rely on during in-person visits.
What to watch
Google emphasizes that AMIE remains a research system and more research is needed before responsible real-world clinical deployment. The company has not announced a timeline or availability for clinical use.
Google Research and Google DeepMind have advanced AMIE, a research medical AI system, to demonstrate expert-level capabilities in real-time clinical video consultations. Built on Gemini and Project Astra using a multi-agent architecture, AMIE now interprets visual and auditory cues, guides virtual physical exams, and performs diagnostic reasoning in real time. This represents a significant expansion from text-based interaction, allowing the system to observe physical signs such as cough, gait, and visible signs of discomfort — the kinds of nonverbal observations that physicians routinely integrate into diagnosis and treatment decisions.
In a randomized study, simulated consultations were conducted with patient actors and evaluated by a group of primary care physicians. Clinical evaluators assessed AMIE across four core competencies: history-taking thoroughness, diagnostic accuracy, management appropriateness, and communication quality. AMIE received favorable assessments across all these domains. Beyond clinical evaluation, patient actors who interacted with the system also preferred the video consultation experience compared to text chat, indicating that the addition of visual communication may enhance patient perception of the interaction.
Despite these encouraging results, Google is careful to underscore that AMIE remains in research and that substantial additional work is required before the system can be deployed responsibly in real clinical settings. The company has not provided details on the timeline, regulatory strategy, or concrete next steps toward clinical availability. The study serves as a proof of concept that AI can perform multimodal clinical assessment in real time, but the path from research demonstration to responsible deployment in actual clinical practice remains open.
AMIE's advancement into real-time video consultation marks a shift in how AI can be applied to clinical work. Previous medical AI systems, including text-based versions of AMIE, operated within the constraints of written dialogue. The new multimodal architecture, built on Gemini and Project Astra, enables the system to process the full range of sensory information — visual and auditory — that human clinicians depend on when evaluating patients. The study's design, using patient actors and primary care physicians as evaluators, provides a controlled setting where AMIE's performance on core clinical competencies could be measured against human expectations.
The preference expressed by patient actors for video over text chat suggests that the addition of visual communication itself may carry therapeutic value beyond diagnostic accuracy alone. However, Google's explicit framing of AMIE as a research system underscores the distance between a favorable demonstration and clinical readiness. The company has not disclosed what additional research or validation steps remain, what regulatory pathways it may pursue, or whether AMIE will eventually be offered as a product or service.
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytime
Ask AI anything about this article. Q&As are published on this page for other readers too.
Security researchers led by Alexander Panfilov discovered a vulnerability in the APIs of all major AI provider…

CEO Sundar Pichai announced that the Gemini app has surpassed 1 billion monthly active users, making it the 14…

River AI, founded by xAI co-founder Igor Babuschkin, raised $1.1 billion in a seed/Series A round led by Gener…

An unreleased Anthropic model significantly increased the lower bound of solutions for which the Riemann hypot…

ONESTRUCTION, Inc. built Ishigaki-IDS, a foundation model specialized for construction industry BIM workflows…

H2O.ai announced on August 11, 2026, that it has joined the Open Secure AI Alliance alongside NVIDIA and other…

The AI news that matters, in one minute each morning.
Sign up free